Are you someone who always tends to eat delicious fast food and fried foods, then this might be the reason why you cannot resist the temptation of these foods! Obesity remains a major global health challenge, increasing the risk of developing serious conditions such as type 2 diabetes, heart disease, and metabolic disorders. While many complex factors contribute to weight gain, the massive availability of high-fat options in every grocery store aisle makes overeating a constant struggle. It’s easy to think of overeating as a problem that originates in the digestive system. However, appetite is controlled almost entirely by the brain. Scientists are still working to piece together how consumed fat interacts with specific neural pathways that determine hunger, cravings, and body weight in the long term.Brain protein linked to appetiteTo find out how this works, Professor Shigenobu Matsumura and his team at Osaka Metropolitan University looked at a protein called optic atrophy 1 (OPA1). OPA1, located within the powerhouses of MC4R neurons in the brain’s hypothalamus, helps keep these appetite-controlling cells working as they should. The team compared normal mice with mice bred without OPA1 in those specific brain cells. To see how the missing protein changed their eating habits, both groups were given an unlimited amount of soybean oil as a fat source.Surprising differencesThe results revealed a stark difference in how male and female brains respond to fatty foods. Soybean oil consumption increased OPA1 levels among normal male mice, but the same dietary fat failed to stimulate this protective increase in normal females. When OPA1 was completely removed, both male and female mice consumed significantly more food, gradually gained weight with age, and eventually became obese. Given a direct choice between regular chow and enriched soybean oil, mice lacking OPA1 gravitated more toward fat, consumed more and gained weight quickly, an effect that was much more severe in female mice. Main effects of weight loss medications. The researchers also evaluated how these biological differences affect treatment by testing setmelanotide, an anti-obesity drug designed to activate the brain’s MC4R receptors.Main effects of weight loss medicationsThe research team also looked at how these brain differences might impact treatment by testing the anti-obesity drug setmelanotide, which targets the brain’s MC4R receptor. The drug successfully suppressed appetite in male mice, whether they had the OPA1 protein or not. But in females who lost OPA1, the drug barely worked. This shows a clear dichotomy in how male and female brains respond to the same weight loss treatment.Move toward personalized treatmentsProfessor Matsumura pointed out that understanding how brain cells process energy gives scientists a much clearer picture of the true causes of obesity. This is because male and female brains process fats and respond to medications differently; Standard obesity treatments may not work equally well for everyone. These findings suggest that future treatments will need to be tailored to biological sex to be truly effective.
